Divalproex Sodium Tablet, Extended Release
Product Images NDC 0615-8376

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 0615-8376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (Divalproex Sodium Er Tab 250mg 8376 500mg 8377 Lup 1)

Chemical structure of divalproex sodium, showing the molecular arrangement including functional groups and sodium ion (Na+). This structure represents the active ingredient in the drug.*

FDA Label Image

Image 2 (Divalproex Sodium Er Tab 250mg 8376 500mg 8377 Lup 2)

A cumulative distribution plot comparing the percentage reduction in CPS rate for patients treated with Divalproex Sodium Delayed-Release versus placebo. The x-axis shows the percentage of patients, while the y-axis represents the percent reduction in CPS rate, with improvements above zero and worsening below zero indicated.*

FDA Label Image

Image 3 (Divalproex Sodium Er Tab 250mg 8376 500mg 8377 Lup 3)

A cumulative percentage curve chart showing the percentage reduction in complex partial seizure (CPS) rate for patients treated with high dose and low dose divalproex sodium delayed release. The x-axis represents the percentage of patients, and the y-axis shows the percent reduction in CPS rate, with improvement indicated upward and worsening downward. Two curves compare treatment effects of high versus low dose.*

FDA Label Image

Image 4 (Divalproex Sodium Er Tab 250mg 8376 500mg 8377 Lup 4)

A bar graph comparing numerical values for Placebo and Divalproex Sodium Extended-Release Tablets. The graph shows the Placebo bar at 0.6 and the Divalproex Sodium bar at 1.2, with an asterisk indicating statistical significance (p=0.006).*

FDA Label Image

Divalproex Sodium Er Tab 250mg Bingo Card Label (Divalproex Sodium Er Tab 250mg 8376 500mg 8377 Lup 5)

Divalproex Sodium ER Tabs USP 250 mg extended release oral tablets with multiple barcode labels. The label includes lot number 8376, space for expiration date, and dosage instructions for once-daily use. Manufactured by Lupin and packaged by Vanguard Labs, Glasgow, KY, the label also states the product is for institutional use only and recommends storage at controlled room temperature (20°-25°C).*

FDA Label Image

Divalproex Sodium Er Tab 500mg Bingo Card Label (Divalproex Sodium Er Tab 250mg 8376 500mg 8377 Lup 6)

This image shows the packaging label for Divalproex sodium extended-release tablets, USP 500 mg. The label includes directions for once-daily dosing and storage at controlled room temperature (20°-25°C). It is packaged by Vanguard Labs, Glasgow, KY 42141, with lot and expiration date fields present but not filled. There is a calendar grid for recording received date and numerous small barcode labels each referencing Divalproex Sodium ER Tab USP 500 mg. The label indicates institutional use, with manufacturing information by Lupin and packaging by Vanguard.*

FDA Label Image

Divalproex Sodium Er Tab 500mg Unit Dose Label (Divalproex Sodium Er Tab 250mg 8376 500mg 8377 Lup 7)

Label sheet for Divalproex Sodium ER Tablets USP 500 mg extended-release tablets. The label includes multiple barcode stickers indicating lot number 8377 and space for expiration date. The main label shows packaging by Vanguard Labs, Glasgow, KY, with instructions to store at 20°-25°C and dispense in a tight, light-resistant container. The product is Rx-only and labeled for once-daily dosing, with a quantity of 30 tablets per package. The label also notes manufacturing by Lupin and repackaging by Vanguard Labs.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.